<DOC>
	<DOCNO>NCT01264133</DOCNO>
	<brief_summary>An open study Evaluate Efficacy , Safety Sustained effect Clevudine monotherapy Adefovir Clevudine combination proportion Roadmap concept Patients chronic hepatitis B .</brief_summary>
	<brief_title>A Study With Clevudine Monotherapy Adefovir Clevudine Combination Patients With Chronic Hepatitis B</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Adefovir</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<mesh_term>Clevudine</mesh_term>
	<criteria>1 . Patient 18 year old . 2 . Patient document HBsAg positive &gt; 6 month . 3 . Patient HBV DNA positive DNA level â‰¥ 2,000 IU/mL within 30 day baseline . 4 . Patient ALT level &gt; =80 IU/L 5 . Patient compensate liver disease ( Patient chronic B Hepatitis liver cirrhosis &lt; = 6 ) 6 . Patient able give write informed consent prior study start comply study requirement . 1 . Patient currently receive antiviral , immunomodulatory , cytotoxic corticosteroid therapy . 2 . Patients previously treat interferon , peginterferon immunomodulatory within previous 6 month . 3 . Patients previously treat clevudine , lamivudine , adefovir , entecavir , telbivudine investigational nucleoside HBV infection . 4 . Patient coinfected HCV , HDV HIV . 5 . Patient history ascites , variceal hemorrhage hepatic encephalopathy . 6 . Patient clinical evidence decompensated liver disease hepatocellular carcinoma 7 . Patient previous liver transplantation 8 . Patient pregnant breastfeeding . 9 . Patient clinically relevant history abuse alcohol drug . 10 . Patient significant immunocompromised , gastrointestinal , renal , hematological , psychiatric , bronchopulmonary , biliary disease exclude asymptomatic GB stone , neurological , cardiac , oncologic ( except HCC ) allergic disease medical illness investigator 's opinion might interfere therapy . 11 . Patient creatinine clearance le 60mL/min estimate follow formula : ( 140age year ) ( body weight [ kg ] ) / ( 72 ) ( serum creatinine [ mg/dL ] ) [ Note : multiply estimate 0.85 woman ]</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>